Skip to main content
The BMJ logoLink to The BMJ
. 2012 Oct 2;345:e5909. doi: 10.1136/bmj.e5909

Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis

Mackenzie R Wehner 1,2, Melissa L Shive 3, Mary-Margaret Chren 4, Jiali Han 5,6, Abrar A Qureshi 5, Eleni Linos 4,
PMCID: PMC3462818  PMID: 23033409

Abstract

Objective To synthesise the literature on indoor tanning and non-melanoma skin cancer.

Design Systematic review and meta-analysis.

Data sources PubMed (1966 to present), Embase (1974 to present), and Web of Science (1898 to present).

Study selection All articles that reported an original effect statistic for indoor tanning and non-melanoma skin cancer were included. Articles that presented no data, such as review articles and editorials, were excluded, as were articles in languages other than English.

Data extraction Two investigators independently extracted data. Random effects meta-analysis was used to summarise the relative risk of ever use versus never use of indoor tanning. Dose-response effects and exposure to indoor tanning during early life were also examined. The population attributable risk fraction for the United States population was calculated.

Results 12 studies with 9328 cases of non-melanoma skin cancer were included. Among people who reported ever using indoor tanning compared with those who never used indoor tanning, the summary relative risk for squamous cell carcinoma was 1.67 (95% confidence interval 1.29 to 2.17) and that for basal cell carcinoma was 1.29 (1.08 to 1.53). No significant heterogeneity existed between studies. The population attributable risk fraction for the United States was estimated to be 8.2% for squamous cell carcinoma and 3.7% for basal cell carcinoma. This corresponds to more than 170 000 cases of non-melanoma skin cancer each year attributable to indoor tanning. On the basis of data from three studies, use of indoor tanning before age 25 was more strongly associated with both squamous cell carcinoma (relative risk 2.02, 0.70 to 5.86) and basal cell carcinoma (1.40, 1.29 to 1.52).

Conclusions Indoor tanning is associated with a significantly increased risk of both basal and squamous cell skin cancer. The risk is higher with use in early life (<25 years). This modifiable risk factor may account for hundreds of thousands of cases of non-melanoma skin cancer each year in the United States alone and many more worldwide. These findings contribute to the growing body of evidence on the harms of indoor tanning and support public health campaigns and regulation to reduce exposure to this carcinogen.

Introduction

The incidence of basal cell carcinoma and squamous cell carcinoma of the skin, collectively termed non-melanoma skin cancer (NMSC), has increased dramatically over previous decades, in what some have termed an epidemic.1 2 NMSC is by far the most common human malignancy, and nearly 30% of white people living in areas of exposure to high ultraviolet radiation will develop an NMSC in their lifetime.3 Because of its high prevalence, NMSC is a considerable financial burden to healthcare systems.4 5 6

Although NMSC is the most common cancer, it is often excluded from national cancer registries and cancer databases because it typically does not affect survival. NMSC is more common in older men, but more tumours have recently been documented in women and in younger people of both sexes.7 8 Besides older age and male sex, major risk factors for development of NMSC include light skin, family history, residence at latitudes near the equator, and exposure to ultraviolet radiation.9 10

Because it is potentially modifiable, indoor tanning is a particularly important type of exposure to ultraviolet radiation. Indoor tanning is a class I carcinogen, considered “carcinogenic to humans” by the International Agency for Research on Cancer.11 Indoor tanning is significantly associated with increased risk of malignant melanoma and was shown to be a potential risk factor for NMSC in a previous, smaller meta-analysis.12 13 Several studies have examined the link between NMSC and indoor tanning.14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 However, the study sizes and the percentage of participants reporting exposure have been small, yielding varied results. Our aim in this study was to synthesise the available data on indoor tanning and NMSC.

Methods

We carried out this review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.30

Literature search

We defined NMSC as either basal cell carcinoma or squamous cell carcinoma and indoor tanning as the use of an ultraviolet emission device to produce a cosmetic tan. The terminology used in the literature is diverse. In this analysis, we considered indoor tanning, sunbed, sunlamp, tanning bed, tanning booth, solarium, artificial tanning, artificial ultraviolet tanning, non-solar ultraviolet tanning, and variations of these to be synonymous with indoor tanning.

We identified studies through searches of electronic databases and by scanning reference lists of articles. We searched PubMed (1966 to present), Embase (1974 to present), and Web of Science (1898 to present). Two authors (MRW and MLS) did the search, and the last search was run on 16 March 2012. Additionally, we reviewed identified articles and reviews on the topics of NMSC and ultraviolet exposure closely to locate additional articles. Specifics of the search strategy used in each database are detailed in the supplementary materials.

All published articles in English that reported an effect statistic for indoor tanning and NMSC or that reported measuring or adjusting for indoor tanning in a study including participants with NMSC were eligible for inclusion. Two authors (MRW and MLS) assessed the eligibility of studies by using the title and abstract for initial screening followed by review of the full text. We excluded articles that presented no data, such as review articles and editorials, and articles in languages other than English. Inclusion criteria for quantitative meta-analysis were studies reporting an effect estimate, such as an odds ratio or hazard ratio, or reporting measurement of or adjustment for indoor tanning that could be used to calculate an effect estimate.

We used a data extraction sheet, which was developed on the basis of the Cochrane Consumers and Communication Review Group’s data extraction template. We extracted the following data items from each study: characteristics of study participants (including age, sex, type of NMSC) and inclusion/exclusion criteria, characteristics of study design (including design type, presence of matching in case-control studies, matching characteristics, and number of controls per case), outcomes (including effect estimates of different doses of exposure to indoor tanning), and statistical methods (including univariate or multivariate analyses, logistic regressions, and variables included).

Statistical methods

For the primary meta-analysis, we used the odds ratio or hazard ratio for ever exposure to indoor tanning, which was the exposure measure used by most of the studies. Ever exposure (for example, participants were asked: “Have you ever used an indoor ultraviolet tanning device to produce a cosmetic tan?”) was available for 10 studies. For two studies, the only available measure was “regular” exposure (Bakos et al17) or greater than five exposures per year (Walther et al28). We thus did the primary analysis on the 10 studies reporting ever exposure and a subsequent sensitivity analysis that included all 12 studies. In one instance, we calculated an unadjusted odds ratio and 95% confidence interval from the raw data of a matched study.14 Data comparing ever use versus never use of indoor tanning came directly from the authors of one study that did not show this comparison in the manuscript.29 We also did a sensitivity analysis excluding four retrospective studies that did not fully adjust for confounders (see supplementary table).14 19 21 27

We did additional analyses on studies that reported effect statistics for high dose exposures and on studies that reported effect statistics for young age at exposure. High dose exposure was assessed by four studies, which used exposure measures of “regular use of tanning beds in lifetime,”17 6-26 years of regular exposure,20 exposure more than five times per year,28 and exposure four times per year.29 Three studies reported young age at first exposure, using 16 years of age or younger,20 less than 20 years of age,25 and “high school/college,” which is typically 14-25 years of age.29 Although these studies used different doses of exposure for high dose exposure and different cut-off ages for young age, these represent the only and thus best available data.

We used Stata 11 statistical software to do random effects model meta-analyses, yielding summary relative risks and 95% confidence intervals. All statistical tests were two sided. We analysed data for basal cell carcinoma and squamous cell carcinoma separately. To investigate variability (heterogeneity) in study outcomes, we used a χ2 test for heterogeneity and an I2 statistic.

We used the STROBE statement guidelines to assess the quality of individual studies.31 Of 16 studies identified, two did not state when data was collected,18 26 three case-control studies did not match cases and controls,19 21 28 and three case-control studies used frequency rather than individual matching.20 25 27 Additionally, nine studies did not clearly report participation rates,15 17 18 19 21 23 26 28 29 and three did not state ages or sexes of participants.22 23 26

To assess potential small study effects and publication bias across studies, we created funnel plots by plotting the effect found by each study against the inverse of its standard error. We reviewed the funnel plot visually and used Begg’s rank correlation test and Egger’s weighted linear regression test for formal testing. This aimed to investigate the possibilities that small studies showing no effects may not be published and that small studies are more likely to be done with less methodological rigor, leading to inaccurate effect estimates.

We calculated population proportional attributable risk as (prevalence of exposure×(RR−1))/(1+prevalence of exposure×(RR−1)), where RR is relative risk. We calculated this for the United States, for which we had representative data on both the incidence of NMSC (estimated at 3 507 693 new cases in 20062) and one year prevalence of indoor tanning (estimated at 13.4% for 200532).

Results

Figure 1 shows the study selection process. Database searches yielded a total of 558 unique publications whose title and abstract were screened. We discarded 536 because of no relevance (n=416), no unique data presented (for example, editorial article or review, n=110), or language other than English (n=10). We examined the remaining 22 articles in full text. Sixteen studies met the inclusion criteria and are included in table 1. We included 12 studies in the quantitative meta-analysis. Excluded from meta-analysis were one study that reported only mean numbers of exposures (numbers of indoor tanning visits),18 one study that grouped patients with basal cell carcinoma, squamous cell carcinoma, and melanoma,24 and two studies that grouped basal cell carcinoma and squamous cell carcinoma together.23 26 These last two studies also used patients admitted to hospital with solid organ cancer as controls, which are unlikely to be representative of the population from which the cases arose.23 26 All four studies showed non-significant associations, although one showed a statistically significant positive association when sunbed exposure was grouped with medical phototherapy.24

graphic file with name wehm006749.f1_default.jpg

Fig 1 PRISMA flow diagram of literature search and study selection for meta-analysis of indoor tanning and non-melanoma skin cancer. BCC=basal cell carcinoma; NMSC=non-melanoma skin cancer; SCC=squamous cell carcinoma

Table 1.

 Summary of studies

Reference Country, year of publication Data collection Diagnosis* Total No No of cases Age (years) % male Exposure†
Studies included in meta-analysis
Asgari et al14 United States, 2011 2004-05 SCC 830 415 43-85 61.9 Ever/never
Aubry and McGibbon15 Canada, 1985 1977-78 SCC 266 92 Unknown 65.8 Ever/never
Bajdik et al16 Canada, 1996 1983-84 BCC; SCC 812 226 BCC; 180 SCC 25-79 100.0 Ever/never
Bakos et al17 Germany, 2011 2004-08 BCC 50 25 19-40 40.0 “Regular” exposure
Corona et al19 Italy, 2001 1995-97 BCC 324 166 ≥18 47.8 Ever/never
Ferrucci et al20 United States, 2011 2006-10 BCC 766 376 <40 30.8 Ever/never
Gon and Minelli21 Brazil, 2011 2006-07 BCC 407 127 18-80 41.7 Ever/never
Han et al22 United States, 2006 1989-98 BCC; SCC 1362 283 BCC; 275 SCC 43-68 0.0 Ever/never
Karagas et al25 United States, 2002 1993-95 BCC; SCC 1436 603 BCC 293 SCC 25-74 59.5 Ever/never
Rosso et al27 Switzerland, 1999 1994-96 BCC; SCC 290 120 BCC; 25 SCC 20-75 52.4 Ever/never
Walther et al28 Germany, 2004 1997-99 BCC 624 213 19-92 48.1 >5 exposures per year‡
Zhang et al29 United States, 2012 1989-2009 BCC; SCC 73 494 5506 BCC; 403 SCC 25-62 0.0 Ever/never§
Studies not included in meta-analysis
Boyd et al18 United States, 2002 Unknown BCC 60 30 20-40 0.0 No of exposures
Herity et al23 Ireland, 1989 1984-85 NMSC 792 202 BCC; 194 SCC Unknown Unknown Ever/never
Hogan et al24 Canada, 1991 1989 Skin cancer¶ 4820 791 BCC; 41 SCC; 15 MM** 10-56 37.3 Ever/never
O’Loughlin et al26 Ireland, 1985 Unknown NMSC 242 58 BCC; 63 SCC Unknown 71.9 “Often” exposed

*BCC=basal cell carcinoma; SCC=squamous cell carcinoma of skin; NMSC=non-melanoma skin cancer (BCC and SCC grouped together in publication); skin cancer (malignant melanoma, BCC, SCC all grouped together in publication).

†Ever/never: measurement of ever exposure to indoor tanning compared with never exposure; “regular” exposure: defined in publication as “regular” exposure to indoor tanning, with no further specifics; “often” exposed: defined in publication as “often” exposed to indoor tanning, with no further specifics.

‡>5 exposures to indoor tanning per year compared with ≤5 exposures per year.

§Ever/never comparison obtained directly from authors.

¶Skin cancer of head and neck.

**MM=malignant melanoma.

The 12 studies included in the meta-analysis were published between 1985 and 2012, used data collected between 1977 and 2010 in six different countries, and included 80 661 total participants and 9328 cases of NMSC. All 12 studies reported or provided raw data for effect estimates as odds ratios or hazard ratios (table 2). When available, we preferentially present effect estimates reported using multivariate models.

Table 2.

 Outcome effect sizes for studies included in primary meta-analysis

Reference Odds ratio (95% CI) Adjustments
Basal cell carcinoma Squamous cell carcinoma
Studies comparing ever exposure with indoor tanning to never exposure
Asgari et al14 1.41 (0.90 to 2.22) None (crude)
Aubry and McGibbon15 13.42 (1.38 to 130.48) Age, sex, eye and hair colour, skin type*, ethnicity, sun exposure†
Bajdik et al16 1.2 (0.7 to 2.2) 1.4 (0.7 to2.7) Age, (sex‡), hair colour, skin type*, ethnicity, sun exposure†
Corona et al19 0.6 (0.3 to 1.2) Age, sex, skin type*, sun exposure†, family history of skin cancer
Ferrucci et al20 1.69 (1.15 to 2.48) Age, sex, body site, skin type*, sun sensitivity§, family history of skin cancer, melanocortin 1 receptor gene non-synonymous variants
Gon and Minelli21 0.31 (0.07 to 1.35) Age, sex, eye colour, hair colour, skin type*, family history of skin cancer, presence of actinic keratosis
Han et al22 1.32 (0.87 to 2.03) 1.44 (0.93 to 2.24) Age, (sex‡), sun exposure†, sun sensitivity§, history of severe sunburns¶, geography**, family history of skin cancer
Karagas et al25 1.5 (1.1 to 2.1) 2.5 (1.7 to 3.8) Age, sex, sun sensitivity§††
Rosso et al27 1.24 (0.53 to 2.88) Age, sex
Zhang et al29 1.29 (1.22 to 1.35)‡‡ 1.50 (1.20 to 1.78)‡‡ Age, (sex‡), hair colour, sun exposure†, sun sensitivity§, history of severe sunburns¶, geography**, number of moles on legs, family history of melanoma
Studies measuring higher dose exposure: “regular” exposure17 or >5 exposures per year28
Bakos et al17 25.0 (2.26 to 277.36) Sunscreen use, parents’ sunscreen use, smoking
Walther et al28 0.7 (0.3 to 1.5) None (crude)

*Skin type: complexion (Aubry and McGibbon), skin colour (Bajdik et al, Ferrucci et al), pigmentary traits (Corona et al).

†Sun exposure: non-occupational sun exposure (Aubry and McGibbon), lifetime occupational sun exposure (Bajdik et al), number of weeks spent at beach before age 20 and outdoor work (Corona et al), cumulative sun exposure while wearing bathing suit (Han et al), outdoor sun exposure (Zhang et al).

‡Study not adjusted for sex because only included one sex.

§Skin sensitivity to sun: skin response to first exposure of season to 1 hour of summer sun and to prolonged exposure to sun (Ferrucci et al), constitutional susceptibility score (Han et al), sun sensitivity (Karagas et al), childhood tendency to sunburn (Zhang et al).

¶History of severe sunburns: lifetime sunburns which blistered (Han et al), number of severe sunburns between 15 and 20 (Zhang et al).

**Geography: geographic region at baseline (Han et al), ultraviolet index in area of residence at birth and 15 and 30 years of age (Zhang et al).

††Adjusted for age and sex in basal cell carcinoma analysis because adjustment for sun sensitivity did not change results.

‡Hazard ratio (95% CI), obtained directly from authors.

Effect estimates for ever exposure to indoor tanning compared with never exposure were available for 10 out of 12 studies. A meta-analysis of these studies yielded summary relative risks of 1.29 (95% confidence interval 1.08 to 1.53) for basal cell carcinoma and 1.67 (1.29 to 2.17) for squamous cell carcinoma (fig 2). A χ2 test for heterogeneity was non-significant for both basal cell carcinoma (P=0.14) and squamous cell carcinoma (P=0.09); I2 statistics were 36.8% (95% confidence interval 0% to 72%) for basal cell carcinoma and 47.1% (0% to 79%) for squamous cell carcinoma. To include all available studies, we did a sensitivity analysis using the effect statistics from all 12 studies, including the two studies that reported only higher dose exposure.17 28 Both studies considered only basal cell carcinoma; with these two studies included, the summary relative risk for basal cell carcinoma was 1.25 (1.01 to 1.55). Funnel plots assessing publication bias were symmetrical for both basal cell carcinoma and squamous cell carcinoma, and all Begg’s and Egger’s tests were not statistically significant, suggesting that publication bias was unlikely. Our results did not change appreciably in a sensitivity analysis excluding four retrospective studies that did not fully adjust for confounders.14 19 21 27

graphic file with name wehm006749.f2_default.jpg

Fig 2 Relative risk of basal cell carcinoma and squamous cell carcinoma in participants ever exposed to indoor tanning compared with participants never exposed to indoor tanning

To assess the presence of a dose-response effect, we did a sub-analysis on studies that included effect estimates for frequent or multiple (high dose) exposures to indoor tanning (table 3, top). High dose exposure was associated with a relative risk of 1.50 (0.81 to 2.77) for basal cell carcinoma. To assess the potential effect of exposure to indoor tanning at a young age, we did a sub-analysis on studies that included effect estimates for early life exposure (table 3, bottom). Indoor tanning exposure before age 25 was associated with a relative risk of 1.40 (1.29 to 1.52) for basal cell carcinoma and 2.02 (0.70 to 5.86) for squamous cell carcinoma.

Table 3.

 Outcome effect sizes for studies included in subset analyses of high dose exposure and young age at exposure

Reference Exposure/age Odds ratio (95% CI)
Basal cell carcinoma Squamous cell carcinoma
Studies assessing high dose exposure to indoor tanning
Bakos et al17 “Regular use of tanning beds in lifetime” 25.0 (2.26 to 277.36)
Ferrucci et al20 6-26 years of “regular”’ exposure 2.16 (1.34 to 3.48)
Walther et al28 >5 exposures per year 0.7 (0.3 to 1.5)
Zhang et al29 4 exposures per year 1.15 (1.11 to 1.19)* 1.15 (1.01 to 1.31)*
Summary relative risk 1.50 (0.81 to 2.77)
Studies assessing young age at exposure to indoor tanning
Ferrucci et al20 ≤16 years of age 1.83 (1.12 to 2.97)
Karagas et al25 <20 years of age 1.8 (1.0 to 3.0) 3.66 (1.9 to 6.9)
Zhang et al29 “High school/college” 1.38 (1.27 to 1.5)† 1.21 (0.85 to 1.71)†
Summary relative risk 1.40 (1.29 to 1.52) 2.02 (0.70 to 5.86)

*Hazard ratio (95% CI).

†Hazard ratio (95% CI) obtained directly from authors.

Population attributable risk

Applying our summary risk estimates to the prevalence of exposure to indoor tanning in the United States, we calculated the population attributable risk fraction at 3.7% for basal cell carcinoma and at 8.2% for squamous cell carcinoma. This corresponds to 98 408 cases of basal cell carcinoma and 72 244 cases of squamous cell carcinoma, making 170 652 cases of non-melanoma skin cancer each year attributable to indoor tanning (see supplementary figure).

Discussion

In this systematic review and meta-analysis of more than 9300 cases of non-melanoma skin cancer from 12 studies, we found a positive, statistically significant association between exposure to indoor tanning and NMSC. Ever exposure to indoor tanning was associated with a 67% higher risk for squamous cell carcinoma and a 29% higher risk for basal cell carcinoma. Exposure to indoor tanning at a young age was significantly associated with an increased risk for basal cell carcinoma and showed a non-significant increased risk for squamous cell carcinoma. High dose exposure to indoor tanning showed a non-significant increased risk for basal cell carcinoma. This suggests a critical period for exposure during early life and a potential dose-response effect.

Possible explanations for findings

A causal link between indoor tanning and NMSC is one possible explanation for our findings. This link is biologically plausible, because both ultraviolet A and ultraviolet B radiations are established carcinogens in animal models and human studies.11 33 Several population based studies have documented rapid rises in skin cancer among young women, coinciding with the adoption of indoor tanning and supporting this causal relation.8 34 35 The dose-response effect noted in several studies further supports this argument.20 29 The temporal relation in which indoor tanning at a young age is a stronger risk factor not only supports a causal interpretation but also implies a critical period of higher susceptibility during early life.

Alternative explanations for these findings include the possibility that these observational and mostly retrospective studies were confounded by skin type or outdoor exposure to ultraviolet radiation. For example, fair skinned people who are more susceptible to NMSC might use indoor tanning more often, and indoor tanners may also get more outdoor ultraviolet exposure.35 Because most of the studies included in the primary meta-analysis (8/10) controlled for skin type or sun sensitivity and many (5/10) controlled for outdoor ultraviolet exposure, we do not feel that this confounding alone could account for the significant associations observed. Also, differential recall of use of indoor tanning in people already diagnosed as having skin cancer is a concern in case-control studies. However, given that prospective cohort studies found similar effect sizes, and are heavily weighted in this meta-analysis, we do not think that recall bias significantly affects our conclusion. Although they are always a concern in literature based meta-analyses, publication bias and small study effects are unlikely to fully explain these findings on the basis of our analyses.

Comparison with other studies

These findings are consistent with a previous meta-analysis of indoor tanning and NMSC,13 which, using only five studies, found a significant increase in risk for squamous cell carcinoma (summary relative risk 2.25, 95% confidence interval 1.08 to 4.70) and a non-significant effect for basal cell carcinoma (summary relative risk 1.03, 0.56 to 1.90). Our analysis, using substantially more studies, found a similarly significantly increased risk for squamous cell carcinoma and, notably, found a significantly increased risk for basal cell carcinoma. Our findings add to the growing body of evidence on the harms of indoor tanning. Indoor tanning is already considered a class I carcinogen on the basis of its effect on malignant melanoma.11 12 Although NMSC is generally not a lethal cancer, it affects a vast number of people worldwide and accounts for a considerable disease burden.1 2 6 36 Although the population attributable risk fraction of indoor tanning on NMSC is modest, when applied to the 3.5 million new cases of NMSC diagnosed each year, indoor tanning may account for hundreds of thousands of new cases each year in the United States alone. Yet this is a global problem: recent studies from Australia, France, Denmark, Germany and Sweden suggest that 10.6-35% of people have used a tanning bed at least once in their lives, and 1.3-29.9% have done so in the previous year.37 38 39 40 41 42 43

Limitations of study

This study is limited by the fact that it included only observational and mostly case-control studies. However, a randomised trial of indoor tanning is not realistic, and most of the included studies controlled for multiple potential confounders, making this the best level of evidence possible. Another potential limitation of this meta-analysis is the broad time period spanned by the data. Included studies collected data from the 1970s to the 2010s, which is important because indoor tanning devices have changed over time from high ultraviolet B output to predominately ultraviolet A output.44 45 46 However, multiple studies have indicated that both ultraviolet B and ultraviolet A seem to be capable of causing significant mutagenic damage to skin.11 33 47 48

Conclusions

Indoor tanning, which is already an established risk factor for malignant melanoma, is probably a risk factor for both squamous cell carcinoma and basal cell carcinoma, which are the most common human cancers. We hope that these findings can support public health campaigns and motivate increased regulation to reduce exposure to this carcinogen, especially during early life.

What is already known on this topic

  • Non-melanoma skin cancer (NMSC) is the most common human cancer

  • Indoor tanning is a known risk factor for malignant melanoma, but the data on NMSC are less clear because small individual studies have resulted in varied effect estimates

What this study adds

  • Indoor tanning is associated with NMSC, especially when exposure occurs early in life

  • This modifiable risk factor accounts for hundreds of thousands of new cancer cases in the United States each year

  • More countries, including the United States, should follow in the footsteps of Europe, Australia, and Canada and restrict tanning bed use for minors

We thank Stephen Bent of the University of California San Francisco and Emanuele Di Angelantonio of the University of Cambridge for their assistance.

Contributors: MRW, M-MC, and EL were involved in the conception and design of the study. MRW, MLS, and EL did the data collection and analysis. MRW, MLS, M-MC, and EL interpreted the data. MRW and EL drafted the manuscript, and all authors critically revised it for important intellectual content. All authors approved the final version to be published. EL is the guarantor.

Funding: This project was supported by award number KL2RR024130 from the National Center for Research Resources of the National Institutes of Health, and by award number K24 AR052667 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. The study sponsors were not involved in the study design and the collection, analysis, and interpretation of data, nor the writing of the article or the decision to submit it for publication. The authors were independent from the study sponsors.

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; MMC does consultancy for Genentech; no other relationships or activities that could appear to have influenced the submitted work.

Ethical approval: Not needed.

Data sharing: No additional data available.

Cite this as: BMJ 2012;345:e5909

Web Extra. Extra material supplied by the author

References

  • 1.Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069-80. [DOI] [PubMed] [Google Scholar]
  • 2.Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7. [DOI] [PubMed] [Google Scholar]
  • 3.Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8. [DOI] [PubMed] [Google Scholar]
  • 4.Chen JG, Fleischer AB Jr, Smith ED, Kancler C, Goldman ND, Williford PM, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001;27:1035-8. [DOI] [PubMed] [Google Scholar]
  • 5.Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003;48:425-9. [DOI] [PubMed] [Google Scholar]
  • 6.Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR. The economic impact of non-melanoma skin cancer: a review. J Natl Comp Canc Netw 2010;8:888-96. [DOI] [PubMed] [Google Scholar]
  • 7.Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2007;157(suppl 2):47-51. [DOI] [PubMed] [Google Scholar]
  • 8.Christenson LJ. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681-90. [DOI] [PubMed] [Google Scholar]
  • 9.Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18. [DOI] [PubMed] [Google Scholar]
  • 10.Wei-Passanese EX, Han J, Lin W, Li T, Laden F, Qureshi AA. Geographical variation in residence and risk of multiple nonmelanoma skin cancers in US women and men. Photochem Photobiol 2012;88:483-9. [DOI] [PubMed] [Google Scholar]
  • 11.El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, et al. A review of human carcinogens—part D: radiation. Lancet Oncol 2009;10:751-2. [DOI] [PubMed] [Google Scholar]
  • 12.Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005;14:562-66. [DOI] [PubMed] [Google Scholar]
  • 13. International Agency for Research on Cancer Working Group on Artificial Ultraviolet (UV) Light And Skin Cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007;120:1116-22. [DOI] [PubMed] [Google Scholar]
  • 14.Asgari MM, White E, Warton EM, Hararah MK, Friedman GD, Chren M-M. Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer 2011;63:314-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of the skin: a case-control study in the Montreal region. Cancer 1985;55:907-11. [DOI] [PubMed] [Google Scholar]
  • 16.Bajdik CD, Gallagher RP, Astrakianakis G, Hill GB, Fincham S, McLean DI. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. Br J Cancer 1996;73:1612-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bakos RM, Kriz M, Mühlstädt M, Kunte C, Ruzicka T, Berking C. Risk factors for early-onset basal cell carcinoma in a German institution. Eur J Dermatol 2011;21:705-9. [DOI] [PubMed] [Google Scholar]
  • 18.Boyd AS, Shyr Y, King LE Jr. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol 2002;46:706-9. [DOI] [PubMed] [Google Scholar]
  • 19.Corona R, Dogliotti E, D’Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001;137:1162-8. [DOI] [PubMed] [Google Scholar]
  • 20.Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol 2011; published online 8 Dec. [DOI] [PMC free article] [PubMed]
  • 21.Gon A, Minelli L. Risk factors for basal cell carcinoma in a southern Brazilian population: a case-control study. Int J Dermatol 2011;50:1286-90. [DOI] [PubMed] [Google Scholar]
  • 22.Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses’ Health Study. Int J Epidemiol 2006;35:1514-21. [DOI] [PubMed] [Google Scholar]
  • 23.Herity B, O’Loughlin G, Moriarty MJ, Conroy R. Risk factors for non-melanoma skin cancer. Ir Med J 1989;82:151-2. [PubMed] [Google Scholar]
  • 24.Hogan DJ, To T, Wilson ER, Miller AB, Robson D, Holfeld K, et al. A study of acne treatments as risk factors for skin cancer of the head and neck. Br J Dermatol 1991;125:343-8. [DOI] [PubMed] [Google Scholar]
  • 25.Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Canc Inst 2002;94:224-6. [DOI] [PubMed] [Google Scholar]
  • 26.O’Loughlin C, Moriarty MJ, Herity B, Daly L. A re-appraisal of risk factors for skin carcinoma in Ireland: a case control study. Ir J Med Sci 1985;154:61-5. [DOI] [PubMed] [Google Scholar]
  • 27.Rosso S, Joris F, Zanetti R. Risk of basal and squamous cell carcinomas of the skin in Sion, Switzerland: a case-control study. Tumori 1999;85:435-42. [DOI] [PubMed] [Google Scholar]
  • 28.Walther U, Kron M, Sander S, Sebastian G, Sander R, Peter RU, et al. Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170-8. [DOI] [PubMed] [Google Scholar]
  • 29.Zhang M, Qureshi AA, Geller AC, Frazier L, Hunter DJ, Han J. Use of tanning beds and incidence of skin cancer. J Clin Oncol 2012;30:1588-93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Heckman CJ, Coups EJ, Manne SL. Prevalence and correlates of indoor tanning among US adults. J Am Acad Dermatol 2008;58:769-80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Council on Scientific Affairs. Harmful effects of ultraviolet radiation. JAMA 1989;262:380-4. [PubMed] [Google Scholar]
  • 34.Hausauer AK, Swetter SM, Cockburn MG, Clarke CA. Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Arch Dermatol 2011;147:783-9. [DOI] [PubMed] [Google Scholar]
  • 35.Purdue MP, Freeman LEB, Anderson WF, Tucker MA. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol 2008;128:2905-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics 2011;29:863-74. [DOI] [PubMed] [Google Scholar]
  • 37.Francis K, Dobbinson S, Wakefield M, Girgis A. Solarium use in Australia, recent trends and context. Aust N Z J Public Health 2010;34:427-30. [DOI] [PubMed] [Google Scholar]
  • 38.Lawler SP, Kvaskoff M, DiSipio T, Whiteman D, Eakin E, Aitken J, et al. Solaria use in Queensland, Australia. Aust N Z J Public Health 2006;30:479-82. [DOI] [PubMed] [Google Scholar]
  • 39.Ezzedine K, Malvy D, Mauger E, Nageotte O, Galan P, Hercberg S, et al. Artificial and natural ultraviolet radiation exposure: beliefs and behaviour of 7200 French adults. J Eur Acad Dermatol Venereol 2008;22:186-94. [DOI] [PubMed] [Google Scholar]
  • 40.Køster B, Thorgaard C, Philip A, Clemmensen I. Sunbed use and campaign initiatives in the Danish population, 2007-2009: a cross-sectional study. J Eur Acad Dermatol Venereol 2011; published online 9 Jan. [DOI] [PubMed]
  • 41.Börner FU, Schütz H, Wiedemann P. A population-based survey on tanning bed use in Germany. BMC Dermatol 2009;9:6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Boldeman C, Bränström R, Dal H, Kristjansson S, Rodvall Y, Jansson B, et al. Tanning habits and sunburn in a Swedish population age 13-50 years. Eur J Cancer 2001;37:2441-8. [DOI] [PubMed] [Google Scholar]
  • 43.Bränström R, Ullén H, Brandberg Y. Attitudes, subjective norms and perception of behavioural control as predictors of sun-related behaviour in Swedish adults. Prev Med 2004;39:992-9. [DOI] [PubMed] [Google Scholar]
  • 44.Diffey BL, Farr PM. Tanning with UVB or UVA: an appraisal of risks. J Photochem Photobiol B 1991;8:219. [DOI] [PubMed] [Google Scholar]
  • 45.Gerber B, Mathys P, Moser M, Bressoud D, Braun-Fahrländer C. Ultraviolet emission spectra of sunbeds. Photochem Photobiol 2002;76:664-8. [DOI] [PubMed] [Google Scholar]
  • 46.Nilsen LTN, Hannevik M, Aalerud TN, Johnsen B, Friberg EG, Veierød MB. Trends in UV irradiance of tanning devices in Norway: 1983-2005. Photochem Photobiol 2008;84:1100-8. [DOI] [PubMed] [Google Scholar]
  • 47.Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001;44:837-46. [DOI] [PubMed] [Google Scholar]
  • 48.Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat 2007;28:578-88. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from The BMJ are provided here courtesy of BMJ Publishing Group

RESOURCES